Fig. 3From: Prognostic impact of angiotensin-converting enzyme inhibitors and angiotensin receptors blockers in esophageal or gastric cancer patients with hypertension - a real-world studyKaplan-Meier estimates of cancer-specific survival stratified by using of ACEIs/ARBs at the post-diagnosis periods of esophageal cancer (upper) and gastric cancer (lower)Back to article page